The DOI matches its Crossref record; 282 of the 282 references it cites were found in a registry or an index.
Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives
Open accessAbstract
Astrocytes play key roles in the regulation of brain energy metabolism, which has a major impact on brain functions, including memory, neuroprotection, resistance to oxidative stress and homeostatic tone. Energy demands of the brain are very large, as they continuously account for 20–25% of the whole body’s energy consumption. Energy supply of the brain is tightly linked to neuronal activity, providing the origin of the signals detected by the widely used functional brain imaging techniques such as functional magnetic resonance imaging and positron emission tomography. In particular, neuroenergetic coupling is regulated by astrocytes through glutamate uptake that triggers astrocytic aerobic glycolysis and leads to glucose uptake and lactate release, a mechanism known as the Astrocyte Neuron Lactate Shuttle. Other neurotransmitters such as noradrenaline and Vasoactive Intestinal Peptide mobilize glycogen, the reserve for glucose exclusively localized in astrocytes, also resulting in lactate release. Lactate is then transferred to neurons where it is used, after conversion to pyruvate, as a rapid energy substrate, and also as a signal that modulates neuronal excitability, homeostasis, and the expression of survival and plasticity genes. Importantly, glycolysis in astrocytes and more generally cerebral glucose metabolism progressively deteriorate in aging and age-associated neurodegenerative diseases such as Alzheimer’s disease. This decreased glycolysis actually represents a common feature of several neurological pathologies. Here, we review the critical role of astrocytes in the regulation of brain energy metabolism, and how dysregulation of astrocyte-mediated metabolic pathways is involved in brain hypometabolism. Further, we summarize recent efforts at preclinical and clinical stages to target brain hypometabolism for the development of new therapeutic interventions in age-related neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–282 of 282
Pawlosky, R. J., Kemper, M. F., Kashiwaya, Y., King, M. T., Mattson, M. P., & Veech, R. L. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13958 · Cited by 108
APOE alters glucose flux through central carbon pathways in astrocytes
Williams, H. C., Farmer, B. C., Piron, M. A., Walsh, A. E., Bruntz, R. C., Gentry, M. S., Sun, R. C., & Johnson, L. A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104742 · Cited by 105
Metformin and the Risk of Dementia in Type 2 Diabetes Patients
Chin-Hsiao, T. (2018) · Aging and Disease · doi:10.14336/ad.2017.1202 · Cited by 104
Beckett, T. L., Studzinski, C. M., Keller, J. N., Murphy, M. P., & Niedowicz, D. M. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.046 · Cited by 103
Neurogenesis and vascularization of the damaged brain using a lactate-releasing biomimetic scaffold
Álvarez, Z., Castaño, Ó., Castells, A. A., Mateos‐Timoneda, M. A., Planell, J. A., Engel, E., & Alcántara, S. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.02.051 · Cited by 103
Hansen, H. H., Barkholt, P., Fabricius, K., Jelsing, J., Terwel, D., Pyke, C., Knudsen, L. B., & Vrang, N. (2015) · Brain Research · doi:10.1016/j.brainres.2015.12.052 · Cited by 102
Keeney, J. T.-R., Ibrahimi, S., & Zhao, L. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-150348 · Cited by 102
Mongeon, R., Venkatachalam, V., & Yellen, G. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6593 · Cited by 100
Palmer, A. M. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050161 · Cited by 100
Chen, S., Sun, J., Zhao, G., Guo, A. W., Chen, Y., Fu, R., & Deng, Y. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2250-8 · Cited by 100
Lactate potentiates angiogenesis and neurogenesis in experimental intracerebral hemorrhage
Zhou, J., Liu, T., Guo, H., Cui, H., Li, P., Feng, D., Hu, E., Huang, Q. B., Yang, A., Zhou, J., et al. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0113-2 · Cited by 100
NH4+ triggers the release of astrocytic lactate via mitochondrial pyruvate shunting
Lerchundi, R., Fernández‐Moncada, I., Contreras‐Baeza, Y., Sotelo-Hitschfeld, T., Mächler, P., Wyss, M. T., Stobart, J. L., Baeza‐Lehnert, F., Alegría, K., Weber, B., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508259112 · Cited by 98
The Contribution of Ketone Bodies to Basal and Activity-Dependent Neuronal Oxidation in Vivo
Chowdhury, G. M. I., Jiang, L., Rothman, D. L., & Behar, K. L. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.77 · Cited by 97
Brandt, J., Buchholz, A. S., Henry-Barron, B. J., Vizthum, D., Avramopoulos, D., & Cervenka, M. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180995 · Cited by 97
Rüb, U., Tredici, K. D., Schultz, C., Thal, D. R., Braak, E., & Braak, H. (2001) · Acta Neuropathologica · doi:10.1007/s004010000320 · Cited by 96
Rachmany, L., Tweedie, D., Li, Y., Rubovitch, V., Holloway, H. W., Miller, J. P., Hoffer, B. J., Greig, N. H., & Pick, C. G. (2012) · AGE · doi:10.1007/s11357-012-9464-0 · Cited by 96
Glucagon like peptide-1 (GLP-1) likes Alzheimer’s disease
Simsir, I. Y., Soyaltın, U. E., & Çetinkalp, Ş. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.03.002 · Cited by 96
Weise, C. M., Chen, K., Chen, Y., Kuang, X., Savage, C. R., & Reiman, E. M. (2018) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.07.016 · Cited by 96
Nutritional ketosis for mild cognitive impairment in Parkinson's disease: A controlled pilot trial
Krikorian, R., Shidler, M. D., Summer, S. S., Sullivan, P. G., Duker, A. P., Isaacson, R., & Espay, A. J. (2019) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2019.07.006 · Cited by 95
Sluggett, J. K., Koponen, M., Bell, J. S., Taipale, H., Tanskanen, A., Tiihonen, J., Uusitupa, M., Tolppanen, A.-M., & Hartikainen, S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz234 · Cited by 95
Koss, E., Friedland, R. P., Ober, B. A., & Jagust, W. J. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.5.638 · Cited by 94
Oxidative damage as an early marker of Alzheimer's disease and mild cognitive impairment
Beal, M. F. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.022 · Cited by 94
Enhancement of Astroglial Aerobic Glycolysis by Extracellular Lactate-Mediated Increase in cAMP
Vardjan, N., Chowdhury, H. H., Horvat, A., Velebit, J., Malnar, M., Muhič, M., Kreft, M., KRIVEC, S. G., Bobnar, S. T., Miš, K., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00148 · Cited by 91
Magistretti, P. J., & Chatton, J. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0171-6 · Cited by 88
Self-citationAllard, J. S., Perez, E. J., Fukui, K., Carpenter, P., Ingram, D. K., & Cabo, R. D. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.012 · Cited by 88
Na+‐Ca2+ cosignaling in the stimulation of the glucose transporter GLUT1 in cultured astrocytes
Porras, O. H., Ruminot, I., Loaiza, A., & Barros, L. F. (2007) · Glia · doi:10.1002/glia.20589 · Cited by 87
Inhibition of the Neuronal Insulin Receptor An in Vivo Model for Sporadic Alzheimer Disease?
Hoyer, S., Lee, S. K., Löffler, T., & Schliebs, R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06932.x · Cited by 87
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease
Barone, E., Tramutola, A., Triani, F., Calcagnini, S., Di Domenico, F., Ripoli, C., Gaetani, S., Grassi, C., Butterfield, D. A., Cassano, T., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1231-5 · Cited by 86
Hypertonic Lactate to Improve Cerebral Perfusion and Glucose Availability After Acute Brain Injury*
Carteron, L., Solari, D., Patet, C., Quintard, H., Miroz, J., Bloch, J., Daniel, R. T., Hirt, L., Eckert, P., Magistretti, P. J., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003274 · Cited by 84
Self-citationMcNeilly, A. D., Williamson, R., Balfour, D. J. K., Stewart, C. A., & Sutherland, C. D. (2012) · Diabetologia · doi:10.1007/s00125-012-2686-y · Cited by 82
Egefjord, L., Gejl, M., Møller, A., Brændgaard, H., Gottrup, H., Antropova, O., Møller, N., Poulsen, H. E., GJEDDE, A. H., Brock, B., et al. (2012) · PubMed · Cited by 80
Lennox, R., Porter, D. W., Flatt, P. R., Hölscher, C., Irwin, N., & Gault, V. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.06.026 · Cited by 79
Cui, Q. N., Stein, L. M., Fortin, S. M., & Hayes, M. R. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15683 · Cited by 74
Jiang, T., Yin, F., Yao, J., Brinton, R. D., & Cadenas, E. (2013) · Aging Cell · doi:10.1111/acel.12127 · Cited by 71
Exendin-4 Ameliorates Traumatic Brain Injury-Induced Cognitive Impairment in Rats
Eakin, K. C., Li, Y., Chiang, Y. H., Hoffer, B. J., Rosenheim, H. M., Greig, N. H., & Miller, J. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082016 · Cited by 70
Jourdain, P., Rothenfusser, K., Benadiba, C., Allaman, I., Marquet, P. P., & Magistretti, P. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-31534-y · Cited by 67
Self-citationCarter, S. F., Chiotis, K., Nordberg, A. K., & Rodriguez‐Vieitez, E. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4217-7 · Cited by 67
Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
Peterson, A. C., & Li, C. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00127 · Cited by 64
Dual-Gene, Dual-Cell Type Therapy against an Excitotoxic Insult by Bolstering Neuroenergetics
Bliss, T. M., Ip, M., Cheng, E., Minami, M., Pellerin, L., Magistretti, P. J., & Sapolsky, R. M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0805-04.2004 · Cited by 63
Self-citationWhite matter and memory in healthy adults: Coupled changes over two years
Bender, A. R., Prindle, J., Brandmaier, A. M., & Raz, N. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.10.085 · Cited by 63
van Gijsel-Bonnello, M., Baranger, K., Benech, P., Rivera, S., Khrestchatisky, M., de Reggi, M., & Gharib, B. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175369 · Cited by 63
Henderson, S. T., & Poirier, J. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-137 · Cited by 61
Ammonium influx pathways into astrocytes and neurones of hippocampal slices
Kelly, T., & Rose, C. R. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07009.x · Cited by 60
A Different View of Lactate in Trauma Patients: Protecting the Injured Brain
Cureton, E. L., Kwan, R. O., Dozier, K. C., Sadjadi, J., Pal, J. D., & Victorino, G. P. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.04.020 · Cited by 59
Robinson, M. M., Lowe, V. J., & Nair, K. S. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01571 · Cited by 58
Crystal structure of a MFS transporter with Ligand at 2.69 Angstroem resolution
Kalbermatter, D., Bosshart, P. D., Bonetti, S., & Fotiadis, D. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb6hcl/pdb · Cited by 58
Bergau, N., Maul, S., Rujescu, D., Simm, A., & Santos, A. N. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00871 · Cited by 57
Dong, J., Wang, Y., Cui, M., Wang, X.-J., Zheng, W.-S., Ma, M., Yang, F., He, D., Hu, Q.-X., Zhang, D., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.09.025 · Cited by 54
Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism?
Giaccari, A., Solini, A., Frontoni, S., & Prato, S. D. (2021) · Diabetes Care · doi:10.2337/dc20-1964 · Cited by 54
Dougherty, R. J., Schultz, S. A., Kirby, T., Boots, E. A., Oh, J. M., Edwards, D. F., Gallagher, C. L., Carlsson, C. M., Bendlin, B. B., Asthana, S., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161067 · Cited by 52
Westhaus, A., Blumrich, E. M., & Dringen, R. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1733-8 · Cited by 51
Brain metabolism and Alzheimer's disease: The prospect of a metabolite-based therapy
Thomas, S. C., Alhasawi, A. A., Appanna, V. D., Auger, C., & Appanna, V. D. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0511-7 · Cited by 51
Rosenbloom, M. H., Barclay, T. R., Kashyap, B., Hage, L. M., O'Keefe, L. R., Svitak, A. L., Pyle, M., Frey, W. H., & Hanson, L. R. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00845-7 · Cited by 51
Chai, T. F., Hong, S. Y., He, H., Zheng, L., Hagen, T., Luo, Y., & Yu, F. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.04.017 · Cited by 50
Targeting Mitochondrial Bioenergetics for Alzheimers Prevention and Treatment
Yao, J., & Brinton, R. D. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072517 · Cited by 50
Executive deficits and regional brain metabolism in Alzheimer's disease
Woo, B. K. P., Harwood, D. G., Melrose, R. J., Mandelkern, M. A., Campa, O., Walston, A., & Sultzer, D. L. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2452 · Cited by 49
Evaluation of neuroprotective effect of glucagon‐like peptide 1 analogs using neuroimaging
Femminella, G. D., & Edison, P. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.12.012 · Cited by 49
Bader, M., Li, Y., Tweedie, D., Shlobin, N. A., Bernstein, A., Rubovitch, V., Tovar‐y‐Romo, L. B., DiMarchi, R. D., Hoffer, B. J., Greig, N. H., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00356 · Cited by 49
Henderson, S. T., Morimoto, B. H., Cummings, J. L., Farlow, M. R., & Walker, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191302 · Cited by 49
Roumes, H., Jollé, C., Blanc, J., Benkhaled, I., Chatain, C. P., Massot, P., Raffard, G., Bouchaud, V., Biran, M., Pythoud, C., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112466118 · Cited by 49
Contribution of astrocytes to metabolic dysfunction in the Alzheimer’s disease brain
Zulfiqar, S., Garg, P., & Nieweg, K. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0140 · Cited by 48
He, W., Wang, H., Zhao, C., Tian, X., Li, L., & Wang, H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29204 · Cited by 45
Yang, Y., Bender, A. R., & Raz, N. (2014) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2014.11.020 · Cited by 44
Ong, Q.-R., Chan, E. S., Lim, M.-L., Cole, G. M., & Wong, B.-S. (2014) · Scientific Reports · doi:10.1038/srep03754 · Cited by 44
Prapong, T., Buss, J. E., Hsu, W. H., Heine, P. A., Greenlee, H. W., & Uemura, E. (2002) · Experimental Neurology · doi:10.1006/exnr.2001.7861 · Cited by 43
Aging, Alzheimer’s Disease and Dysfunctional Glycolysis; Similar Effects of Too Much and Too Little
Hipkiss, A. R. (2019) · Aging and Disease · doi:10.14336/ad.2019.0611 · Cited by 43
Tomi, M., Zhao, Y., Thamotharan, S., Shin, B., & Devaskar, S. U. (2012) · Brain Research · doi:10.1016/j.brainres.2012.11.050 · Cited by 42
Hansen, H. H., Fabricius, K., Barkholt, P., Mikkelsen, J. D., Jelsing, J., Pyke, C., Knudsen, L. B., & Vrang, N. (2016) · Brain Research · doi:10.1016/j.brainres.2016.05.038 · Cited by 42
Manninen, T., Saudargienė, A., & Linne, M. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008360 · Cited by 39
Amyloid β-Peptide Inhibits Neuronal Glucose Uptake by Preventing Exocytosis
Uemura, E., & Greenlee, H. W. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7719 · Cited by 37
van Gijsel‐Bonnello, M., Baranger, K., Benech, P., Rivera, S., Khrestchatisky, M., Reggi, M. L. D., & Gharib, B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194586 · Cited by 36
Role of astrocytic glycolytic metabolism in Alzheimer’s disease pathogenesis
Fu, W., & Jhamandas, J. H. (2014) · Biogerontology · doi:10.1007/s10522-014-9525-0 · Cited by 35
Decreased Brain Glucose Metabolism in Microvessels from Patients with Alzheimer's Diseasea
Marcus, D. L., & Freedman, M. L. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48476.x · Cited by 34
Astrocytes and neurons communicate via a monocarboxylic acid shuttle
Roosterman, D., & Cottrell, G. (2020) · AIMS Neuroscience · doi:10.3934/neuroscience.2020007 · Cited by 34
Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias
Bonomi, C. G., Lucia, V. D., Mascolo, A. P., Assogna, M., Motta, C., Scaricamazza, E., Sallustio, F., Mercuri, N. B., Koch, G., & Martorana, A. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.05.011 · Cited by 31
Fluid Brain Glycolysis: Limits, Speed, Location, Moonlighting, and the Fates of Glycogen and Lactate
Barros, L. F., Martín, A. S., Ruminot, I., Sandoval, P. Y., Baeza‐Lehnert, F., Arce‐Molina, R., Rauseo, D., Contreras‐Baeza, Y., Galaz, A., & Valdivia, S. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03005-2 · Cited by 30
Preventing Alzheimer's disease by means of natural selection
Demetrius, L., & Driver, J. A. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0919 · Cited by 25
Dewsbury, L. S., Lim, C. K., & Steiner, G. Z. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa180 · Cited by 24
Bi, Q., Wang, W., Niu, N., Li, H., Wang, Y., Huang, W., Chen, K., Xu, K., Zhang, J., Chen, Y., et al. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117591 · Cited by 23
Modulation of glucose metabolism and metabolic connectivity by β-amyloid
Carbonell, F., Zijdenbos, A. P., McLaren, D. G., Iturria‐Medina, Y., Bedell, B. J., & Initiative, A. D. N. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16654492 · Cited by 22
Editorial: Insulin and The Brain
Taouis, M., & Torres‐Alemán, I. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00299 · Cited by 18
de Melo, I. S., Pacheco, A. L. D., dos Santos, Y. M. O., Figueiredo, L. M., Nicácio, D. C. S. P., Cardoso-Sousa, L., Duzzioni, M., Gitaí, D. L. G., Tilelli, C. Q., Silva, R. S., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02133-8 · Cited by 16
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
“404 – 406 These cells not only respond to signals from leptin and insulin but also adapt to alterations in brain metabolism to accommodate behavioral changes by controlling glucose transport.”
BackgroundHuman iPSC-derived glia models for the study of neuroinflammation
Stöberl, N., Maguire, E., Salis, E., Shaw, B., & Hall-Roberts, H. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02919-2 · Cited by 71
The role of glial autophagy in Alzheimer’s disease
Litwiniuk, A., Juszczak, G. R., Stankiewicz, A. M., & Urbańska, K. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02242-5 · Cited by 54
Walecha, V., & Luthra, P. M. (2025) · Neurochemical Research · doi:10.1007/s11064-025-04559-9 · Cited by 12
Wang, J. D. J., Teo, A. Y. T., Xiao, B., Chao, Y., Zhou, Z. D., Tan, B. J.-W., Chan, L.-L., Rosalie, E., & Tan, E.-K. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00568-y
Metadata
- Authors
- Beard, E., Lengacher, S., Dias, S., Magistretti, P. J., & Finsterwald, C.
- Venue
- Frontiers in Physiology
- Publisher
- Frontiers Media SA
- Published
- 2022-01-11
- Volume
- 12
- Pages
- 825816-825816
- ISSN
- 1664-042X (ISSN-L)
- OpenAlex
- W4206174876
- Cited by
- 302
- References
- 282
- FWCI
- 22.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.